Startseite Novel AQP2 mutation causing congenital nephrogenic diabetes insipidus: challenges in management during infancy
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Novel AQP2 mutation causing congenital nephrogenic diabetes insipidus: challenges in management during infancy

  • Rottanat Rugpolmuang , Asma Deeb , Yousef Hassan , Tawatchai Deekajorndech , Vorasuk Shotelersuk und Taninee Sahakitrungruang EMAIL logo
Veröffentlicht/Copyright: 15. August 2013

Abstract

Congenital nephrogenic diabetes insipidus (NDI) is a rare inherited disorder, mostly caused by AVPR2 mutations. Less than 10% of cases are due to mutations in the aquaporin-2 (AQP2) gene. Diagnosis and management of this condition remain challenging especially during infancy. Here, we report two unrelated patients, a 6-month-old Thai boy and a 5-year-old Emirati girl, with a history of failure to thrive, chronic fever, polydipsia, and polyuria presented in early infancy. The results of water deprivation test were compatible with a diagnosis of NDI. The entire coding regions of the AVPR2 and AQP2 gene were amplified by polymerase chain reaction and sequenced. Patient 1 was homozygous for a novel missense AQP2 mutation p.G96E, inherited from both parents. Patient 2 harbored a previously described homozygous p.T126M mutation in the AQP2 gene. Both patients were treated with a combination of thiazide diuretics and amiloride. Patient 1 developed paradoxical hyponatremia and severe dehydration 2 weeks after medical treatment began. In conclusion, we report a novel mutation of the AQP2 gene and highlight an important role of genetic testing for definite diagnosis. Vigilant monitoring of the fluid status and electrolytes after beginning the therapy is mandatory in infants with NDI.


Corresponding author: Taninee Sahakitrungruang, MD, Assistant Professor of Pediatrics, Division of Pediatric Endocrinology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand, Phone: +662-256-4996 (ext 115), Fax: +662-256-4911, E-mail:

We are grateful to Ms. Siraprapa Tongkobpetch and Mr. Chalurmpon Srichomthong for their technical assistance. This study was supported by the Thailand Research Fund (to V.S. and T.S.), National Research University Project of Thailand, Office of the Higher Education Commission (HR1163A), and Ratchadapisek Sompotch Fund (RES560530177HR), Faculty of Medicine, Chulalongkorn University.

Conflict of interest statement

Authors’ conflict of interest disclosure: None of the authors has personal or financial conflict of interests.

References

1. Wesche D, Deen PM, Knoers NV. Congenital nephrogenic diabetes insipidus: the current state of affairs. Pediatr Nephrol 2012;27:2183–204.10.1007/s00467-012-2118-8Suche in Google Scholar PubMed

2. Babey M, Kopp P, Robertson GL. Familial forms of diabetes insipidus: clinical and molecular characteristics. Nat Rev Endocrinol 2011;7:701–14.10.1038/nrendo.2011.100Suche in Google Scholar PubMed

3. Deen PM, Verdijk MA, Knoers NV, Wieringa B, Monnens LA, et al. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 1994;264:92–5.10.1126/science.8140421Suche in Google Scholar PubMed

4. Robben JH, Knoers NV, Deen PM. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol 2006;291:F257–70.10.1152/ajprenal.00491.2005Suche in Google Scholar PubMed

5. Onozaki A, Suzuki H, Imamura N, Katoh T, Watanabe T. Congenital nephrogenic diabetes insipidus with marked hyponatremia. Clin Exp Nephrol 2001;5:265–7.10.1007/s10157-001-8024-1Suche in Google Scholar

6. Boussemart T, Nsota J, Martin-Coignard D, Champion G. Nephrogenic diabetes insipidus: treat with caution. Pediatr Nephrol 2009;24:1761–3.10.1007/s00467-009-1187-9Suche in Google Scholar PubMed

7. Anton-Gamero M, Garcia-Martinez E, Fernandez-Ramos J, Rodríguez-Salas M, Gil-Campos M. Nephrogenic diabetes insipidus: the key element of paradoxical hyponatremia. Pediatr Nephrol 2009;24:2277–8.10.1007/s00467-009-1236-4Suche in Google Scholar PubMed

8. Sahakitrungruang T, Wacharasindhu S, Sinthuwiwat T, Supornsilchai V, Suphapeetiporn K, et al. Identification of two novel aquaporin-2 mutations in a Thai girl with congenital nephrogenic diabetes insipidus. Endocrine 2008;33:210–4.10.1007/s12020-008-9074-xSuche in Google Scholar PubMed

9. Sahakitrungruang T, Tee MK, Rattanachartnarong N, Shotelersuk V, Suphapeetiporn K, et al. Functional characterization of vasopressin receptor 2 mutations causing partial and complete congenital nephrogenic diabetes insipidus in Thai families. Horm Res Paediatr 2010;73:349–54.10.1159/000308167Suche in Google Scholar PubMed

10. Collins JS, Schwartz CE. Detecting polymorphisms and mutations in candidate genes. Am J Hum Genet 2002;71:1251–2.10.1086/344344Suche in Google Scholar PubMed PubMed Central

11. Sasaki S. Aquaporin 2: from its discovery to molecular structure and medical implications. Mol Aspects Med 2012;33:535–46.10.1016/j.mam.2012.03.004Suche in Google Scholar PubMed

12. Lin SH, Bichet DG, Sasaki S, Kuwahara M, Arthus MF, et al. Two novel aquaporin-2 mutations responsible for congenital nephrogenic diabetes insipidus in Chinese families. J Clin Endocrinol Metab 2002;87:2694–700.10.1210/jcem.87.6.8617Suche in Google Scholar PubMed

13. Mulders SM, Knoers NV, Van Lieburg AF, Monnens LA, Leumann E, et al. New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels. J Am Soc Nephrol 1997;8:242–8.10.1681/ASN.V82242Suche in Google Scholar PubMed

14. Sato N, Ishizaka H, Yagi H, Matsumoto M, Endo K. Posterior lobe of the pituitary in diabetes insipidus: dynamic MR imaging. Radiology 1993;186:357–60.10.1148/radiology.186.2.8421734Suche in Google Scholar PubMed

15. Ranadive SA, Ersoy B, Favre H, Cheung CC, Rosenthal SM, et al. Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus. Clin Endocrinol (Oxf) 2009;71:388–93.10.1111/j.1365-2265.2008.03513.xSuche in Google Scholar PubMed PubMed Central

16. Kim GH, Lee JW, Oh YK, Chang HR, Joo KW, et al. Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel. J Am Soc Nephrol 2004;15:2836–43.10.1097/01.ASN.0000143476.93376.04Suche in Google Scholar PubMed

17. Morello JP, Salahpour A, Laperriere A, Bernier V, Arthus MF, et al. Pharmacological chaperones rescue cell surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 2000;105:887–95.10.1172/JCI8688Suche in Google Scholar PubMed PubMed Central

18. Yang B, Zhao D, Verkman AS. Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation. FASEB J 2009;23:503–12.10.1096/fj.08-118422Suche in Google Scholar PubMed PubMed Central

Received: 2013-3-13
Accepted: 2013-7-15
Published Online: 2013-08-15
Published in Print: 2014-01-01

©2014 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Editorials
  4. Editorial
  5. Consensus, guidelines and reviews
  6. Review article
  7. Adaptation of glucose metabolism to fasting in young children with infectious diseases: a perspective
  8. Images in pediatric endocrinology
  9. Coexistence of testicular microlithiasis with parathyroid adenoma in an obese child
  10. Original articles
  11. Remission of hypertension and electrolyte abnormalities following renal transplantation in a patient with apparent mineralocorticoid excess well documented throughout childhood
  12. Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study
  13. Glycemic control in familial vs. sporadic type 1 diabetes patients over 5 years
  14. Clinical and laboratory features of temporary brittle bone disease
  15. Age of thelarche and menarche in contemporary US females: a cross-sectional analysis
  16. Teriparatide (rhPTH) treatment in children with syndromic hypoparathyroidism
  17. Retinol and retinyl palmitate in fetal mice liver: sexual dimorphism
  18. Skeletal maturation and predicted adult height in children with premature adrenarche
  19. Homozygosity for a DTDST mutation in a child with multiple epiphyseal dysplasia
  20. Body composition in young patients with galactose metabolic disorders: a preliminary report
  21. Detection of vascular risk markers in children and adolescents with type 1 diabetes
  22. X-linked recessive nephrogenic diabetes insipidus: a clinico-genetic study
  23. Factors influencing neonatal thyroid-stimulating hormone concentrations as a measure of population iodine status
  24. Pediatric idiopathic intracranial hypertension and the underlying endocrine-metabolic dysfunction: a pilot study
  25. Patient reports
  26. Hypothalamic hamartoma associated with central precocious puberty and growth hormone deficiency
  27. A pediatric patient with Cushing syndrome caused by ectopic ACTH syndrome and concomitant pituitary incidentalomas
  28. A novel genetic mutation in a Portuguese family with GCK-MODY
  29. Permanent neonatal diabetes mellitus in monozygotic twins achieving low-dose sulfonylurea therapy
  30. Hypocalcemia in a paediatric case: from the clinical features to diagnosis
  31. A rare case of osteogenesis imperfecta combined with complete tooth loss
  32. Iatrogenic acute pancreatitis due to hypercalcemia in a child with pseudohypoparathyroidism
  33. Clinical expression of familial Williams-Beuren syndrome in a Turkish family
  34. The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma
  35. Low-level hyperinsulinism with hypoglycemic spells in an infant with mosaic Turner syndrome and mild Kabuki-like phenotype: a case report and review of the literature
  36. Multiple cutaneous hemangiomas in a patient with combined pituitary hormone deficiency
  37. Premature thelarche related to fennel tea consumption?
  38. A novel insertion in the FOXL2 gene in a Chilean patient with blepharophimosis ptosis epicanthus inversus syndrome type I
  39. Zellweger syndrome: prenatal and postnatal growth failure with epiphyseal stippling
  40. Marine-Lenhart syndrome in a young girl
  41. Novel AQP2 mutation causing congenital nephrogenic diabetes insipidus: challenges in management during infancy
  42. Letter to the Editors
  43. Mutational analysis of KISS1 and KISS1R in idiopathic central precocious puberty
  44. Carotid intima media thickness and echocardiography in risk stratification of obese adolescents with non-alcoholic fatty liver disease: what is the “right” approach?
  45. Vitamin D and the heart: what is the truth?
Heruntergeladen am 21.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0097/html
Button zum nach oben scrollen